Invesco Pharmaceuticals ETF
PJP
87 hedge funds and large institutions have $65.9M invested in Invesco Pharmaceuticals ETF in 2023 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 27 reducing their positions, and 9 closing their positions.
0% more funds holding
Funds holding: 87 → 87 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
0% less capital invested
Capital invested by funds: $66M → $65.9M (-$61.9K)
0.77% less ownership
Funds ownership: 21.39% → 20.61% (-0.77%)
37% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$2.38M |
| 2 |
PWW
Pettyjohn Wood & White
Lynchburg,
Virginia
|
+$1.53M |
| 3 |
HAS
HBW Advisory Services
Simi Valley,
California
|
+$1.09M |
| 4 |
QAM
Q3 Asset Management
Birmingham,
Michigan
|
+$1.06M |
| 5 |
EH
Equitable Holdings
New York
|
+$205K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$6.68M |
| 2 |
Goldman Sachs
New York
|
-$2.56M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$880K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$759K |
| 5 |
Stifel Financial
St. Louis,
Missouri
|
-$407K |
PJP Hedge Fund Activity: Q2 2023 in Review
87 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q2 2023, worth a combined $65.9M — down 0.09% from $66M a quarter earlier.
Fund positioning in PJP was balanced in Q2 2023: 9 funds opened new positions, 9 closed out, 17 added to existing stakes and 27 trimmed.
The largest buyer was Wells Fargo, adding an estimated $2.38M. The largest seller was Morgan Stanley, cutting an estimated $6.68M.
- 87 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q2 2023, unchanged from Q1 2023.
- Funds reported $65.9M of Invesco Pharmaceuticals ETF stock for Q2 2023, down 0.09% quarter-over-quarter.
- 9 funds opened new Invesco Pharmaceuticals ETF positions in Q2 2023 and 9 closed out, a net change of 0 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q2 2023 was Wells Fargo, an estimated $2.38M added.
- The largest Invesco Pharmaceuticals ETF seller in Q2 2023 was Morgan Stanley, an estimated $6.68M sold.
Based on aggregated 13F filings for Q2 2023.